Henry-Amar M - Search Results

1

André M, Henry-Amar M, Blaise D, Colombat P, Fleury J, Milpied N, Cahn JY, Pico JL, Bastion Y, Kuentz M, Nedellec G, Attal M, Fermé C, Gisselbrecht C. André M, et al. Blood. 1998 Sep 15;92(6):1933-40. Blood. 1998. PMID: 9731050 Free article.

2

Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.

Dietrich PY, Caignard A, Diu A, Genevee C, Pico JL, Henry-Amar M, Bosq J, Angevin E, Triebel F, Hercend T. Dietrich PY, et al. Blood. 1992 Nov 1;80(9):2419-24. Blood. 1992. PMID: 1421414 Free article.

3

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.

Henry-Amar M. Henry-Amar M. Ann Oncol. 1992 Sep;3 Suppl 4:117-28. doi: 10.1093/annonc/3.suppl_4.s117. Ann Oncol. 1992. PMID: 1450072

4

Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.

Socié G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Socié G, et al. Blood. 1991 Jul 15;78(2):277-9. Blood. 1991. PMID: 2070065 Free article.

5

Leukemia following Hodgkin's disease.

Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D, et al. Kaldor JM, et al. N Engl J Med. 1990 Jan 4;322(1):7-13. doi: 10.1056/NEJM199001043220102. N Engl J Med. 1990. PMID: 2403650 Free article. Clinical Trial.

6

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

Tubiana M, Henry-Amar M, Carde P, Burgers JM, Hayat M, Van der Schueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas J, et al. Tubiana M, et al. Blood. 1989 Jan;73(1):47-56. Blood. 1989. PMID: 2462943 Free article. Clinical Trial.

7

Lymphoblastic lymphoma in adults: a clinicopathological study of 34 cases treated at the Institut Gustave-Roussy.

Salloum E, Henry-Amar M, Caillou B, Friedman S, Pico JL, Bayle C, Hayat M. Salloum E, et al. Eur J Cancer Clin Oncol. 1988 Oct;24(10):1609-16. doi: 10.1016/0277-5379(88)90053-3. Eur J Cancer Clin Oncol. 1988. PMID: 3208805

8

Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.

Henry-Amar M. Henry-Amar M. NCI Monogr. 1988;(6):65-72. NCI Monogr. 1988. PMID: 3352791

9

Second cancer risk after interferon therapy?

Troussard X, Henry-Amar M, Flandrin G. Troussard X, et al. Blood. 1994 Nov 1;84(9):3242-4. Blood. 1994. PMID: 7949198 Free article. Clinical Trial. No abstract available.

10

Hodgkin's disease management and follow-up revisited.

Fermé C, Henry-Amar M. Fermé C, et al. Nouv Rev Fr Hematol (1978). 1994 Jun;36(3):209-12. Nouv Rev Fr Hematol (1978). 1994. PMID: 7971241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters